Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs. 

Biotechnology

Cara Therapeutics

Christopher Posner

Jo Goncalves

Ryan Maynard

Iris Francesconi

Beth Weinberg

Scott Terrillion

Eric Vandal

Frédérique Menzaghi

The leadership team at Cara Therapeutics has a wealth of experience in the pharmaceutical industry. The team includes individuals who have worked as vice presidents at companies such as Celgene and LEO Pharma, as well as a brand safety leader at Novartis. The team is also highly educated, with members holding degrees from prestigious universities such as the University of Cape Town.

Leadership Team

CEO and Executive Team

Board of Directors

Leadership Team

About

Team members

Other teams at Cara Therapeutics

CEO and Executive Team

Board of Directors